1. Sequential thin-layer chromatography of propranolol
2. Chatterjee, S. QbD Considerations for Analytical methods – FDA Perspective. Presented at the IFPAC Annual Meeting, Baltimore, CMC Lead for QbD ONDQA/CDER/FDA. https://qbdworks.com/wp-content/uploads/2014/06/AnalyticalQbDIFPAC.pdf (accessed Jan 25, 2013).
3. Tang, Y. QbD Approaches to Analytical Methods – FDA Perspective. FDA/CDER/ONDQA, AAPS: Washington, DC, 2011. https://www.fda.gov/downloads/AboutFDA/CentersOffices/…/CDER/UCM301056.pdf; https://www.fda.gov/media/84046/download (accessed Oct 25, 2011).
4. Ermer, J. Quality by Design in Pharmaceutical Analysis Conference Organized by European Compliance Academy, Vienna, Austria, 2013. http://www.gmp-compliance.org/daten/seminarpdf.archiv/ECA_QbD_in_Analysis_2013.pdf.